Eye Med Distributor's $100M Suit Barred By Deal, Akorn Says
Generic-drug maker Akorn Inc. on Friday asked a New York federal court to dismiss most claims from Fera Pharmaceuticals LLC's $100 million suit accusing it of trade secrets theft, breach of...To view the full article, register now.
Already a subscriber? Click here to view full article